NCT00831350View on ClinicalTrials.gov

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

PHASE2CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

December 31, 2012

Conditions

Retinal Vein OcclusionPosterior Vitreous Detachment

Interventions

DRUG

Ranibizumab

Subjects will receive study medication ranibizumab 0.5mg. Re-treatment will occur monthly through 6 injections

Trial Locations (1)

63110

Barnes Retina Institute, St Louis

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Barnes Retina Institute

OTHER